MedTrace Logo

A Study of a Hydrocolloid Bandage on Pimples

NCT05012735 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2022-09-16

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and tolerability of a hydrocolloid bandage on pimples when used overnight for one week.

Conditions

  • Acne Vulgaris

Interventions

DRUG

Study Cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5)

Participants will wash their face with the study cleanser (Neutrogena Ultra Gentle Daily Cleanser with Pro Vitamin B5) for up to 14 days.

DEVICE

Prototype Ultrathin Hydrocolloid Bandage

Participants will cover their closed and popped pimples in the evening with one or two bandages from Days 0 through 6.

Sponsors & Collaborators

  • Johnson & Johnson Consumer Inc. (J&JCI)

    lead INDUSTRY

Principal Investigators

  • Summer Acevedo, PhD · Stephens SGS, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-19
Primary Completion
2021-09-13
Completion
2021-09-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05012735 on ClinicalTrials.gov